Civin CI - Search Results

1

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax.

Moses BS, McCullough S, Fox JM, Mott BT, Bentzen SM, Kim M, Tyner JW, Lapidus RG, Emadi A, Rudek MA, Kingsbury TJ, Civin CI. Moses BS, et al. Among authors: civin ci. Blood Adv. 2021 Feb 9;5(3):711-724. doi: 10.1182/bloodadvances.2020003429. Blood Adv. 2021. PMID: 33560385 Free PMC article.

2

Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs.

Fox JM, Moynihan JR, Mott BT, Mazzone JR, Anders NM, Brown PA, Rudek MA, Liu JO, Arav-Boger R, Posner GH, Civin CI, Chen X. Fox JM, et al. Among authors: civin ci. Oncotarget. 2016 Feb 9;7(6):7268-79. doi: 10.18632/oncotarget.6896. Oncotarget. 2016. PMID: 26771236 Free PMC article.

3

Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia.

Emadi A, Kapadia B, Bollino D, Bhandary B, Baer MR, Niyongere S, Strovel ET, Kaizer H, Chang E, Choi EY, Ma X, Tighe KM, Carter-Cooper B, Moses BS, Civin CI, Mahurkar A, Shetty AC, Gartenhaus RB, Kamangar F, Lapidus RG. Emadi A, et al. Among authors: civin ci. Leukemia. 2021 Jul;35(7):1907-1924. doi: 10.1038/s41375-020-01080-6. Epub 2020 Nov 16. Leukemia. 2021. PMID: 33199836 Free PMC article.

4

A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology.

Kagan AB, Moses BS, Mott BT, Rai G, Anders NM, Rudek MA, Civin CI. Kagan AB, et al. Among authors: civin ci. Front Oncol. 2022 Jan 11;11:790037. doi: 10.3389/fonc.2021.790037. eCollection 2021. Front Oncol. 2022. PMID: 35127495 Free PMC article.

5

Regulation of RAB5C is important for the growth inhibitory effects of MiR-509 in human precursor-B acute lymphoblastic leukemia.

Tan YS, Kim M, Kingsbury TJ, Civin CI, Cheng WC. Tan YS, et al. Among authors: civin ci. PLoS One. 2014 Nov 4;9(11):e111777. doi: 10.1371/journal.pone.0111777. eCollection 2014. PLoS One. 2014. PMID: 25368993 Free PMC article.

6

Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.

Kingsbury TJ, Kim M, Civin CI. Kingsbury TJ, et al. Among authors: civin ci. Adv Cancer Res. 2019;141:1-42. doi: 10.1016/bs.acr.2018.12.001. Epub 2019 Jan 16. Adv Cancer Res. 2019. PMID: 30691681 Review.

7

MicroRNAs as regulators and effectors of hematopoietic transcription factors.

Kim M, Civin CI, Kingsbury TJ. Kim M, et al. Among authors: civin ci. Wiley Interdiscip Rev RNA. 2019 Sep;10(5):e1537. doi: 10.1002/wrna.1537. Epub 2019 Apr 21. Wiley Interdiscip Rev RNA. 2019. PMID: 31007002 Review.

8

Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study.

Mott BT, He R, Chen X, Fox JM, Civin CI, Arav-Boger R, Posner GH. Mott BT, et al. Among authors: civin ci. Bioorg Med Chem. 2013 Jul 1;21(13):3702-7. doi: 10.1016/j.bmc.2013.04.027. Epub 2013 Apr 22. Bioorg Med Chem. 2013. PMID: 23673218 Free PMC article.

9

A simple high-throughput technology enables gain-of-function screening of human microRNAs.

Cheng WC, Kingsbury TJ, Wheelan SJ, Civin CI. Cheng WC, et al. Among authors: civin ci. Biotechniques. 2013 Feb;54(2):77-86. doi: 10.2144/000113991. Biotechniques. 2013. PMID: 23384178 Free PMC article.

10

MIR144 and MIR451 regulate human erythropoiesis via RAB14.

Kim M, Tan YS, Cheng WC, Kingsbury TJ, Heimfeld S, Civin CI. Kim M, et al. Among authors: civin ci. Br J Haematol. 2015 Feb;168(4):583-97. doi: 10.1111/bjh.13164. Epub 2014 Oct 14. Br J Haematol. 2015. PMID: 25312678 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters